Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

VALERIO, Maria Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.381
EU - Europa 6.126
AS - Asia 5.559
SA - Sud America 946
Continente sconosciuto - Info sul continente non disponibili 732
AF - Africa 126
OC - Oceania 7
Totale 24.877
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.031
SG - Singapore 1.999
RU - Federazione Russa 1.543
CN - Cina 1.294
IT - Italia 1.252
DE - Germania 785
BR - Brasile 709
FI - Finlandia 610
VN - Vietnam 541
HK - Hong Kong 537
UA - Ucraina 427
BD - Bangladesh 406
PL - Polonia 332
GB - Regno Unito 300
FR - Francia 233
IE - Irlanda 190
JP - Giappone 184
CA - Canada 175
SE - Svezia 141
IN - India 128
KR - Corea 101
AR - Argentina 92
MX - Messico 62
NL - Olanda 55
IQ - Iraq 53
TR - Turchia 53
BE - Belgio 47
ES - Italia 44
AT - Austria 42
CO - Colombia 38
EC - Ecuador 33
UZ - Uzbekistan 29
PK - Pakistan 27
RO - Romania 27
VE - Venezuela 27
ZA - Sudafrica 26
JM - Giamaica 25
AE - Emirati Arabi Uniti 23
IR - Iran 22
CR - Costa Rica 20
ID - Indonesia 20
MY - Malesia 19
PH - Filippine 18
GR - Grecia 17
HN - Honduras 17
MA - Marocco 16
KE - Kenya 15
SA - Arabia Saudita 15
TN - Tunisia 15
CI - Costa d'Avorio 14
DZ - Algeria 14
PY - Paraguay 13
CL - Cile 12
CZ - Repubblica Ceca 12
CH - Svizzera 11
NP - Nepal 11
EG - Egitto 10
KZ - Kazakistan 9
TH - Thailandia 9
AL - Albania 8
LT - Lituania 8
PE - Perù 8
RS - Serbia 8
GE - Georgia 7
GT - Guatemala 7
LB - Libano 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
EE - Estonia 6
IL - Israele 6
JO - Giordania 6
SV - El Salvador 6
AU - Australia 5
BG - Bulgaria 5
BO - Bolivia 5
BY - Bielorussia 5
PA - Panama 5
AZ - Azerbaigian 4
BH - Bahrain 4
ET - Etiopia 4
EU - Europa 4
NI - Nicaragua 4
NO - Norvegia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BZ - Belize 3
MN - Mongolia 3
NG - Nigeria 3
OM - Oman 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
DK - Danimarca 2
DM - Dominica 2
HT - Haiti 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MD - Moldavia 2
Totale 24.115
Salva come PNG Salva come JPEG
Città #
Singapore 1.359
Ashburn 1.243
San Jose 995
Fairfield 862
Chandler 539
Hong Kong 517
Woodbridge 490
Wilmington 446
Houston 379
Ann Arbor 360
Seattle 347
Moscow 306
Zgierz 293
Cambridge 284
Council Bluffs 252
Jacksonville 232
Santa Clara 218
Beijing 209
Dublin 191
Los Angeles 188
New York 182
Ho Chi Minh City 177
Tokyo 172
Medford 170
Dallas 160
Palermo 142
Des Moines 141
Hefei 138
Hanoi 137
Lauterbourg 131
Frankfurt am Main 125
Princeton 108
Boardman 107
Altamura 104
Nanjing 99
The Dalles 95
Chicago 94
Milan 91
Buffalo 90
Lawrence 79
Rome 74
São Paulo 74
Helsinki 72
San Diego 64
Tulsa 59
Dearborn 56
Ludwigshafen am Rhein 53
London 50
Brussels 45
Orem 42
Toronto 42
Montreal 41
Nuremberg 41
Shenyang 39
Tianjin 38
Jinan 36
Venice 36
Atlanta 35
Hebei 35
Brooklyn 33
Phoenix 33
Seongnam 33
Munich 32
Da Nang 31
Seoul 31
Rio de Janeiro 29
Denver 28
Nanchang 28
Falls Church 26
Lappeenranta 26
Columbus 25
Naples 25
Warsaw 25
Boston 24
Chennai 24
Memphis 24
San Francisco 24
Stockholm 24
Vancouver 24
Changsha 23
Tashkent 23
Berlin 22
Guangzhou 22
Jiaxing 22
Paris 22
Poplar 22
Baghdad 21
Amsterdam 20
Haiphong 20
Kerken 20
Vienna 20
Washington 19
Zhengzhou 19
Brasília 18
Charlotte 18
Catania 17
City of London 17
Curitiba 17
Kumar 17
Ningbo 17
Totale 14.149
Salva come PNG Salva come JPEG
Nome #
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 351
Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients 336
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 314
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers 298
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 298
Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success 290
Surviving Twenty Years to Bone and Liver Metastatic Breast Cancer: A Case Reported by Treating Oncologists and the Patient Herself 287
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma 286
Clinical presentation and treatment of gastrointestinal stromal tumors. 285
Abemaciclib: safety and effectiveness of a unique cyclin-dependent kinase inhibitor 283
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 278
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 278
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 277
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 277
Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale 270
Gastric and Rectal Metastases from Malignant Melanoma Presenting with Hypochromic Anemia and Treated with Immunotherapy 266
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 265
L'impiego del Tachosil in chirurgia epatica 260
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents 252
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. 237
Alexithymia and coping style in women going to visit in a breast cancer center. 235
Metastatic seeding of colon adenocarcinoma manifesting as synchronous breast and chest wall localization: report of a case. 235
Axillary Nodal Burden in Breast Cancer Patients With Pre-operative Fine Needle Aspiration-proven Positive Lymph Nodes Compared to Those With Positive Sentinel Nodes 234
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 233
A Practical Narrative Review on the Role of Magnesium in Cancer Therapy 230
A Case of Follicular Tumor of Uncertain Malignant Potential (FT-UMP) with Glomeruloid Features Showing Capsular Mucinous Degeneration 230
Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study). 229
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer 228
A phase II study of capecitabine oxaliplatin chemotherapy in metastatic breast cancer patients pretreated with anthracyclines and taxanes 227
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 222
Analysis of Ki-ras mutations in stage I rectal carcinomas and respective regional lymphonodes 221
Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers 218
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors 213
Evaluation of predictive factors for i-CLARAS (intraoperative complications in laparoscopic renal and adrenal surgery): a multicentre international retrospective cohort study 212
Detection of free-circulating tumor DNA in plasma of patients with gastrointestinal cancer. 204
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. 201
Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation 200
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients 200
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials. 199
Cardiotossicità e Cardioprotezione. 196
Effects of hypolipidemic and hypoglycemic agents on atherogenic small, dense LDL in Type 2 diabetes 196
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation 195
Mutational analysis of BRCA1 gene in sicilian patient at risk for inherited breast and/or ovarian cancer: experience of reference center the biomolecular characterization of neoplasm and genetic screening of hereditary tumors. 193
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome 193
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study 193
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 191
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 190
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). 189
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma 189
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: The MITO-2 randomized phase III trial 189
Epirubicina (EPI ) e Docetaxel (DOC ) come chemioterapia primaria ( C P ) nel trattamento del carcinoma mammario localmente avanzato ( CMLA ). VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 187
Current Role of Intraoperative Frozen Section Examination of Sentinel Lymph Node in Early Breast Cancer 185
Liposomal-encapsulated doxorubicin plus cyclophosphamide as first-line therapy in metastatic breast cancer: a phase II multicentric study 184
Gastric metastasis from breast cancer 184
A phase 2 study of Oxaliplatin ( O ) – Capecitabine( C ) chemotherapy in metastatic breast cancer ( MBC ) patients pretreated with Anthracyclines and taxanes VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 183
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study 183
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study 181
TP53 mutations are not prognostic independent indicators in bladder cancer. 178
Studio di phase II: Docetaxel settimanale come seconda linea chemioterapia nel carcinoma prostatico avanzato. 178
The Use of Gemcitabine in heavily pretreted breast cancer patients 176
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study. 176
Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study 176
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) 176
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer 175
Alexithymia and copyng style in women going to visit in a breast cancer center 175
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004 174
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study 174
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA) 172
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study 171
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer 167
Effects of the number of removed lymph nodes on survival outcome in patients with sentinel node-negative breast cancer 164
RUOLO DELL’ECOCOLOR DOPPLER TISSUTALE NELLA VALUTAZIONE DELLA CARDIOTOSSICITÀ DA CHEMIOTERAPICI 161
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 159
Hematologic toxicity of radium-223 in elderly patients with metastatic Castration Resistant Prostate Cancer: a real-life experience 159
Comprehensive Axillary Management of Clinically Node-Positive (cN plus ) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy 157
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer 157
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis 156
Relationship between the thymidylate synthase, p53 levels with the treatment by Cyclophosphamide, Metotrexate, 5-Fluorouracil chemotherapy (CMF) versus Docetaxel (TXT) in the locally advanced carcinoma of breast. 154
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel 154
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer 154
GRUPPO ONCOLOGICO ITALIA MERIDIONALE. NOVEL ASSOCIATION WITH GEMCITABINE AND DOCETAXEL AS SALVAGE CHEMOTHERAPY IN METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH ANTHRACYCLINES: RESULT OF A NULTICENTER PHASE II STUDY 152
Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated? 151
NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience 151
Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma 150
Impressive objective response to nab-paclitaxel plus trastuzumab as fifth line therapy in aelderly her2-positive breast cancer patient 149
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study 147
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma 146
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up 144
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review 140
TP53 mutations are not prognostic indipendent indicators in bladder cancer 139
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data 138
Accuracy and Outcomes of Sentinel Lymph Node Biopsy in Male with Breast Cancer: A Narrative Review and Expert Opinion 136
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World 136
Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study 135
A Narrative Review of the Role of Immunotherapy in Metastatic Carcinoma of the Colon Harboring a BRAF Mutation 133
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 132
Lapatinib activity in a patient with encephalic metastases from trastuzumab-resistant her-2 positive breast cancer 131
A Prospective Observational Study on the Structuring Process and Implementation of a Large Regional, Inter-hospital, Virtual Multidisciplinary Tumor Board on Prostate Cancer 130
STUDIO DI FASE II: DOCETAXEL SETTIMANALE COME SECONDA LINEA CHEMIOTERAPICA NEL CARCINOMA PROSTATICO AVANZATO 128
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma 126
Totale 19.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.384
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022974 0 0 26 76 69 48 84 67 147 156 81 220
2022/20231.607 166 310 29 155 189 243 105 110 164 8 72 56
2023/2024987 41 127 80 72 62 138 181 55 25 19 58 129
2024/20252.704 71 198 249 205 119 80 191 189 188 312 293 609
2025/202610.120 677 416 632 731 980 1.284 1.229 1.015 783 1.077 596 700
2026/20272.008 647 310 1.051 0 0 0 0 0 0 0 0 0
Totale 24.877